Study of tilrekimig for people with severe asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests an investigational medicine called tilrekimig for people with severe asthma that is not well controlled. The goal is to see if it can reduce asthma attacks and improve breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had severe asthma for at least 12 months
- You have had at least 2 asthma attacks in the past year that needed steroids or a hospital visit
- You show improvement in lung function after using a rescue inhaler during screening
- You are on a medium or high dose inhaled steroid plus another controller medicine for at least 12 months
- You have not used oral steroids within 28 days of screening
- You have not had a biologic treatment for asthma or other conditions recently
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medicine called tilrekimig for people with severe asthma that isn't well controlled. It aims to reduce asthma attacks and improve breathing.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
This study tests a new medicine called tozorakimab for adults whose asthma is not well controlled despite using their usual inhalers. It aims to see if it can reduce asthma attacks and improve symptoms.
This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.
This Phase 2 study checks how glycopyrronium bromide works in children with asthma, including its safety and how well inhaler dosing is tolerated. It also uses breathing tests and inhaler technique checks to confirm your child meets key asthma and lung function requirements.
This trial tests a new drug called IBI3002 for people with moderate to severe asthma that isn't well controlled with standard inhalers. It aims to see if the drug is safe and tolerable when given multiple times.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.